Financial stability is increasingly compromised as the current ratio plummeted from 12.99 in 2025Q2 to 0.25 in 2026Q1, reflecting rapid liquidity erosion.
| Total Current Assets | 63.42M | 223.82M | 2.51M | 616.93K | 309.57K | 269.44K |
| Cash & Short-Term Investments | 35.3M | 22.58M | 2.27M | 525.5K | 186.92K | 94.69K |
| Cash Only | 35.3M | 22.58M | 2.27M | 525.5K | 186.92K | 94.69K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 5.88M | 2.81K | 36.85K | 28K | 12.12K | 13.47K |
| Days Sales Outstanding | 137.15 | 0.56 | 4.95 | 2.71 | 1.17 | 1.96 |
| Inventory | 0 | 0 | 4.3K | 63.2K | 49.57K | 59.77K |
| Days Inventory Outstanding | 0.01 | - | 0.44 | 102 | 118.73 | 13.73 |
| Other Current Assets | 8.18M | 199.06M | 0 | 225 | 60.96K | 101.51K |
| Total Non-Current Assets | 557.34M | 506.79M | 1.17M | 482.27K | 637.43K | 178.2K |
| Property, Plant & Equipment | 0 | 0 | 764.58K | 471K | 622.93K | 171.57K |
| Fixed Asset Turnover | 12.89x | - | 3.56x | 8.00x | 6.08x | 14.60x |
| Goodwill | 93.51M | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 446.76M | 470.56M | 388.34K | 0 | 0 | 0 |
| Long-Term Investments | 98.54M | 35.7M | 0 | 0 | 0 | 6.63K |
| Other Non-Current Assets | 186K | 534.3K | 19.43K | 11.28K | 14.51K | 0 |
| Total Assets | 620.76M | 730.61M | 3.68M | 1.1M | 947K | 447.64K |
| Asset Turnover | 0.01x | 0.00x | 0.74x | 3.43x | 4.00x | 5.59x |
| Asset Growth % | 59872.91% | 19764.31% | 234.61% | 16.07% | 111.55% | - |
| Total Current Liabilities | 251.7M | 215.99M | 606.05K | 814.45K | 327.9K | 118.29K |
| Accounts Payable | 0 | 5.86M | 323.73K | 0 | 0 | 47.5K |
| Days Payables Outstanding | 59.03 | 192.88 | 33.17 | - | - | 10.91 |
| Short-Term Debt | 209.74M | 209.56M | 139.28K | 148.52K | 92.55K | 53.54K |
| Deferred Revenue (Current) | 23.12M | 0 | 2.27K | 3.42K | 8.6K | 17.25K |
| Other Current Liabilities | 18.84M | 568.21K | 0 | 567.81K | 166.26K | 0 |
| Current Ratio | 0.25x | 1.04x | 4.13x | 0.76x | 0.94x | 2.28x |
| Quick Ratio | 0.25x | 1.04x | 4.13x | 0.68x | 0.79x | 1.77x |
| Cash Conversion Cycle | 78.13 | - | -27.78 | - | - | 4.78 |
| Total Non-Current Liabilities | 1.99M | 365.97K | 503.63K | 393.17K | 238.09K | 56.27K |
| Long-Term Debt | 0 | 0 | 0 | 228.87K | 0 | 0 |
| Capital Lease Obligations | 1.2M | 365.97K | 503.63K | 164.29K | 238.09K | 56.27K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 366K | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 253.69M | 216.35M | 1.11M | 1.21M | 565.98K | 174.56K |
| Total Debt | 209.74M | 209.92M | 783.68K | 636.38K | 391.13K | 109.81K |
| Net Debt | 174.44M | 187.34M | -1.49M | 110.88K | 204.21K | 15.12K |
| Debt / Equity | 0.57x | 0.41x | 0.31x | - | 1.03x | 0.40x |
| Debt / EBITDA | -0.65x | - | - | - | - | 0.88x |
| Net Debt / EBITDA | -0.54x | - | - | - | - | 0.12x |
| Interest Coverage | -24.72x | -6.40x | -8.19x | -27.96x | - | - |
| Total Equity | 367.07M | 514.26M | 2.57M | -108.41K | 381.01K | 273.09K |
| Equity Growth % | 57541.59% | 19923.15% | 2469.03% | -128.45% | 39.52% | - |
| Book Value per Share | 23.07 | 45.25 | 0.48 | -0.02 | 0.06 | 0.05 |
| Total Shareholders' Equity | 367.07M | 514.26M | 2.57M | -108.41K | 381.01K | 273.09K |
| Common Stock | 690K | 439.95K | 6.05K | 4.62K | 4.43K | 273.09K |
| Retained Earnings | -298.78M | -60M | -7.78M | -4.16M | -2.54M | 0 |
| Treasury Stock | 0 | -749K | -22.14K | 0 | 0 | 0 |
| Accumulated OCI | -131K | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Rapid capital consumption
As reported in recent financial statements, Nakamoto Inc.'s total assets surged from $9.9 million in 2025Q2 to $620.8 million by 2026Q1, a shift primarily driven by goodwill accumulation rather than organic growth, which suggests a fundamental disconnect between the company's reported balance sheet size and its underlying clinical performance.
The dramatic expansion of the asset base appears to be an accounting artifact of aggressive acquisition activity rather than a reflection of improved business quality. Investors should monitor whether these intangible assets face future impairment, as the current revenue contraction makes the justification for such high goodwill valuations increasingly difficult to support.
Based on the company's reported figures, the current ratio plummeted from 12.99 in 2025Q2 to 0.25 in 2026Q1, indicating that Nakamoto Inc. has rapidly exhausted its short-term liquidity buffer while attempting to scale its clinical operations in a high-burn environment that warrants significant caution from prospective capital providers.
The collapse in the current ratio suggests that current liabilities are now significantly outpacing liquid assets, leaving the company with little margin for error. This liquidity crunch appears to be a direct consequence of the company's inability to align its operating expenses with its declining revenue base.
According to recent SEC filings, Nakamoto Inc.'s retained earnings have deteriorated to a deficit of $298.8 million as of 2026Q1, reflecting a persistent pattern of value destruction that has severely eroded the company's equity base and raises questions regarding the long-term sustainability of its current capital structure.
The deepening deficit in retained earnings highlights the cumulative impact of years of negative operating margins. This trend suggests that the company is effectively consuming its own equity to fund ongoing clinical losses, which may necessitate future dilutive financing if the current burn rate remains unchecked.
As indicated by the provided balance sheet data, goodwill ballooned to $93.5 million in 2026Q1, representing a significant portion of total assets that appears disconnected from the company's declining revenue trajectory and suggests a high risk of future non-cash impairment charges that could further destabilize the equity position.
The reliance on goodwill to bolster the asset side of the balance sheet is a red flag for fundamental analysts, as it often masks the lack of tangible value creation in distressed healthcare models. Investors should consider the possibility that these intangible assets are significantly overvalued relative to the company's current ability to generate cash flow.
Quick answers to the most common questions about buying NAKA stock.
As of 2025, Nakamoto Inc. (NAKA) had total assets of $730.6M including $223.8M in current assets.
Nakamoto Inc. (NAKA) carries total debt of $209.9M, offset by $22.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Nakamoto Inc. (NAKA) has total shareholders' equity (book value) of $514.3M ($45.25 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Nakamoto Inc. (NAKA) reported a current ratio of 1.04x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.